Indeed, treatment with IL-8 neutralizing antibody led to a significant reduction of tumor burden in the hindlimb of mice, osteolytic bone lesion areas, and osteoclasts within bone-metastatic lesions in the hindlimb of mice (Fig. 7B–D). This evidence concerns the gene CXCL8 and neoplasm.